Categories
Awareness campaigns Child health chronic illness chronic pain Disability Educational EVENTS Healthcare Info site invisible illness Juvenile arthritis Medical Conditions / Disorders Musculoskeletal Patient Advocacy Patients Professionals Rheumatoid arthritis Rheumatology The hints and tips station

Patients & Caregivers | American College of Rheumatology | Find information you need about rheumatic diseases & conditions.

Working in tandem with the Health Care Professionals is not easy for many patients, so it is important for the person that you care for to make their healthcare team aware that ‘you’ are their personal care-provider and support system.

Categories
Awareness campaigns chronic illness Chronic SoMe platforms clinical trials Disability Educational EVENTS genetics invisible illness Medical Conditions / Disorders Medical news stories Medical news stories, blogs and research pharma Pharma Pharma / Science / Tech / Digital / AI Professionals Rare Research Video

How Clinical Trials Are Evolving | CheckRare.com

In this video Dr. Weinreb discusses the fact that as we learn more about diseases and illnesses, and their subtypes, that it is “becoming common for clinical trials to be more focused on small subsets of a disease to better target the therapy.”

Categories
Articles Blogs / Bloggers celiac Charities chronic illness Educational EVENTS events Food, drink and recipes Gastro / Gut / Bowel Healthcare Info site invisible illness Medical Conditions / Disorders Newsletters/Papers/Magazines/Blogs Patient Advocacy Podcast Professionals The hints and tips station Therapies and Treatments Twitter Feed

Ellen Bayens | The Celiac Scene News | Issue: August 2019

Research Study Seeks Celiacs Between 12 – 25 Years Old

Categories
About Us - FibroFlutters AI in medicine Awareness campaigns chronic illness clinical trials conference Digital Health Drug development events EVENTS eyeforpharma genetics genomics Healthcare Machine learning Medical Conditions / Disorders Medical Device NICE ~ National Institute for Health and Care Excellence NIHR NIHR Clinical Research Network Patient & Public Involvement & Engagement Patient Research Ambassador Initiative Parkinsons Patient Advocacy Patients Patients included Pharma pharma Pharma / Science / Tech / Digital / AI Professionals public health Rare Research

I’m speaking at the @eyeforpharma PATIENT SUMMIT EUROPE | Pharma’s home for patient-centricity in Europe

“For 2019, we have a practical focus on transforming the whole pipeline – R&D, clinical trials and commercial – demonstrating how patient-led design can reduce cost whilst driving effectiveness and value.”

Categories
About Us - FibroFlutters Awareness campaigns Blogs / Bloggers chronic illness FibroFlutters Home News Healthcare invisible illness Medical Conditions / Disorders Newsletters Newsletters/Papers/Magazines/Blogs Patient Advocacy Patients pharma Pharma / Science / Tech / Digital / AI Professionals public health Rare Twitter

Fibroflutters #SocialMedia #healthadvocacy and #allstakeholder approach to #healthcare, across the globe – Peeking at the statistics!

The burning question now 14 months on from that is how are FibroFlutters representing and engaging with ‘all-stakeholders’ themselves. After all it really would be rude of us to demand the industry to respect such a notion and for us not to return the favour and do it ourselves.

Categories
About Us - FibroFlutters AI in medicine Articles Awareness campaigns big data chronic illness conference Deep learning Digital Health Drug development EVENTS eyeforpharma Healthcare invisible illness Machine learning Medical Conditions / Disorders Medical Device Patient Advocacy Patients Patients included Pharma pharma Pharma / Science / Tech / Digital / AI Professionals public health Rare

What’s coming up? #pharma #patients @eyeforpharma? Take a look & see! (sponsored)

Hello and welcome to this eyeforpharma event special where I share with you the upcoming conferences in Philadelphia – North America and in London – Europe, during October 2019 Many people possibly will wish to know why I champion eyeforpharma, and indeed pharma in general so I’ll go into it, ‘briefly’, here before introducing the […]